cilostazol has been researched along with Bronchial Hyperreactivity in 3 studies
Bronchial Hyperreactivity: Tendency of the smooth muscle of the tracheobronchial tree to contract more intensely in response to a given stimulus than it does in the response seen in normal individuals. This condition is present in virtually all symptomatic patients with asthma. The most prominent manifestation of this smooth muscle contraction is a decrease in airway caliber that can be readily measured in the pulmonary function laboratory.
Excerpt | Relevance | Reference |
---|---|---|
"The effect of a single oral dose of cilostazol on BHR was studied in 10 elderly patients with clinically stable asthma, with a mean age of 59." | 9.08 | Effect of a phosphodiesterase 3 inhibitor, cilostazol, on bronchial hyperresponsiveness in elderly patients with asthma. ( Fujimura, M; Hashimoto, T; Kamio, Y; Matsuda, T; Myou, S, 1997) |
"The effect of a single oral dose of cilostazol on BHR was studied in 10 elderly patients with clinically stable asthma, with a mean age of 59." | 5.08 | Effect of a phosphodiesterase 3 inhibitor, cilostazol, on bronchial hyperresponsiveness in elderly patients with asthma. ( Fujimura, M; Hashimoto, T; Kamio, Y; Matsuda, T; Myou, S, 1997) |
" The aim of this study was to assess the influence of selective inhibitors of PDE3 (cilostazol) and PDE4 (citalopram) on cough and airway reactivity." | 3.74 | Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity. ( Beharkova, M; Feherova, Z; Mokra, D; Mokry, J; Nosalova, G, 2008) |
" Effects of cilostazol and vesnarinone (selective PDE III inhibitors), rolipram (selective PDE IV inhibitor) and theophylline (nonselective PDE inhibitor) on LPS-induced bronchial hyperreactivity were investigated in guinea pigs." | 3.70 | Effects of isoenzyme selective phosphodiesterase inhibitors on bacterial lipopolysaccharide-induced bronchial hyperreactivity in guinea pigs. ( Nagai, H; Tanaka, H; Uno, T, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mokry, J | 1 |
Mokra, D | 1 |
Nosalova, G | 1 |
Beharkova, M | 1 |
Feherova, Z | 1 |
Fujimura, M | 1 |
Kamio, Y | 1 |
Myou, S | 1 |
Hashimoto, T | 1 |
Matsuda, T | 1 |
Uno, T | 1 |
Tanaka, H | 1 |
Nagai, H | 1 |
1 trial available for cilostazol and Bronchial Hyperreactivity
Article | Year |
---|---|
Effect of a phosphodiesterase 3 inhibitor, cilostazol, on bronchial hyperresponsiveness in elderly patients with asthma.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Administration, Oral; Aged; Asthma; Bronchial Hyperreactivity; | 1997 |
2 other studies available for cilostazol and Bronchial Hyperreactivity
Article | Year |
---|---|
Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity.
Topics: Animals; Antigens; Antitussive Agents; Blood Cell Count; Bronchial Hyperreactivity; Bronchoconstrict | 2008 |
Effects of isoenzyme selective phosphodiesterase inhibitors on bacterial lipopolysaccharide-induced bronchial hyperreactivity in guinea pigs.
Topics: Acetylcholine; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cilostazol; Guinea | 1998 |